The Cooper Companies, Inc. COO Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Coopersurgical Segment | $358M+7.6% | $329M+3.3% | $355.4M+3.9% | $341.9M+4.5% | $332.7M+8.5% | |
| Coopervision Segment | $723.5M+8.0% | $695.1M+7.6% | $709.7M+4.9% | $718.4M+6.3% | $669.6M+5.3% | |
| Net Sales by Product | ||||||
| Fertility | $143.8M+13.3% | $126.6M+5.8% | $140.9M+1.2% | $137.1M+6.0% | $126.9M+2.5% | |
| Office and surgical | $214.2M+4.1% | $202.4M+1.8% | $214.5M+5.8% | $204.8M+3.5% | $205.8M+12.5% | |
| Sphere, other | $358.6M+5.1% | $343.9M+5.3% | $365M+3.3% | $359.6M+3.0% | $341.2M+4.8% | |
| Toric and multifocal | $364.9M+11.1% | $351.2M+10.0% | $344.7M+6.7% | $358.8M+9.9% | $328.4M+5.8% | |
| Net Sales by Geography | ||||||
| Europe | $341.6M+17.0% | $326.4M+13.5% | $1.46B+6.2% | $343.1M+15.5% | $291.9M+5.5% | |
| Rest of world | $192.1M-1.6% | $183.8M+1.7% | —— | $201M+3.3% | $195.2M+4.4% | |
| United States | $547.8M+6.3% | $513.9M+3.5% | $526.2M+4.1% | $516.2M+1.0% | $515.2M+7.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does The Cooper Companies, Inc. break its business down?
- The Cooper Companies, Inc. (COO) reports net sales by business across 2 parts — Coopersurgical Segment and Coopervision Segment. Each is extracted from the segment footnotes and tracked over time.
- Where does The Cooper Companies, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in The Cooper Companies, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
